Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetes.
Matthew W SegarKershaw V PatelMuthiah VaduganathanMelissa C CaugheyByron C JaegerMujeeb BasitDuwayne WillettJaved ButlerPartho P SenguptaThomas J WangDarren K McGuireAmbarish PandeyPublished in: Diabetologia (2021)
Clustering using FMMs was the optimal phenomapping strategy to identify replicable subgroups of patients with type 2 diabetes with distinct clinical characteristics, CVD risk and response to therapies.